-+ 0.00%
-+ 0.00%
-+ 0.00%

HC Wainwright & Co. Maintains Buy on Greenwich LifeSciences, Raises Price Target to $70

Benzinga·11/18/2026 12:28:10
Listen to the news
HC Wainwright & Co. analyst Yi Chen maintains Greenwich LifeSciences (NASDAQ:GLSI) with a Buy and raises the price target from $69 to $70.